These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1482817)

  • 21. Specialty pharmaceuticals: developing a management plan.
    Willcutts D
    Manag Care Q; 2002; 10(4):26-9. PubMed ID: 12561391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Billing for cognitive services: understanding Québec pharmacists' behavior.
    Kröger E; Moisan J; Grégoire JP
    Ann Pharmacother; 2000 Mar; 34(3):309-16. PubMed ID: 10917375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacy expenditures: the challenges of balancing access, cost, and value.
    Am J Manag Care; 2003 Jun; Suppl Decision Maker News():1-4. PubMed ID: 12866364
    [No Abstract]   [Full Text] [Related]  

  • 24. Healthcare. A prescription for controversy.
    Markels A
    US News World Rep; 2003 Oct; 135(11):50, 52. PubMed ID: 14618748
    [No Abstract]   [Full Text] [Related]  

  • 25. Entry of new pharmacies in the deregulated Norwegian pharmaceuticals market--consequences for costs and availability.
    Rudholm N
    Health Policy; 2008 Aug; 87(2):258-63. PubMed ID: 18164509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug pricing in AFP--how much does a drug cost?
    Siwek J
    Am Fam Physician; 2010 Jan; 81(2):125. PubMed ID: 20082507
    [No Abstract]   [Full Text] [Related]  

  • 27. Stats & facts. Pharmaceutical utilization contributes to the rise in pharmacy costs.
    Manag Care Interface; 2000 Dec; 13(12):52-3. PubMed ID: 11147547
    [No Abstract]   [Full Text] [Related]  

  • 28. The cost-effectiveness of a clinical pharmacist intervention among elderly outpatients.
    Cowper PA; Weinberger M; Hanlon JT; Landsman PB; Samsa GP; Uttech KM; Schmader KE; Lewis IK; Cohen HJ; Feussner JR
    Pharmacotherapy; 1998; 18(2):327-32. PubMed ID: 9545151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of new pharmaceutical agents on pharmacy budgets.
    Kozma CM
    Manag Care Interface; 1999 Jan; 12(1):77-8. PubMed ID: 10345243
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical pharmacist intervention in a primary care medical group reduces financial losses.
    Curtiss FR
    J Manag Care Pharm; 2004; 10(4):355. PubMed ID: 15298533
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmaceutical insurance and the demand for prescription pharmaceuticals in Västerbotten, Sweden.
    Rudholm N
    Scand J Public Health; 2005; 33(1):50-6. PubMed ID: 15764241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States.
    Lobb WB; Wilkin NE; Holmes ER
    Int J Pharm Compd; 2015; 19(6):514-20. PubMed ID: 26891565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The problems associated with home care in pharmacy].
    Nagadomi N; Norimine T; Motegi R; Kawasaki Y; Nagashima K; Kashima H
    Gan To Kagaku Ryoho; 2008 Dec; 35 Suppl 1():59-61. PubMed ID: 20443308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution and cost of drugs in a pharmaceutically decentralized health maintenance organization.
    Hardigan WD; Slywka GW; Eng HJ
    Contemp Pharm Pract; 1980; 3(1):23-30. PubMed ID: 10245109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specialty pharmacy management adjusts to new financial realities.
    Reinke T
    Manag Care; 2013 Apr; 22(4):13-4. PubMed ID: 23678558
    [No Abstract]   [Full Text] [Related]  

  • 36. Mapping the route to medication therapy management documentation and billing standardization and interoperabilility within the health care system: meeting proceedings.
    Millonig MK
    J Am Pharm Assoc (2003); 2009; 49(3):372-82. PubMed ID: 19357067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Do pharmacists and the state increase drug costs?].
    Kaesback W
    MMW Fortschr Med; 1999 Dec; 141(48):54. PubMed ID: 10766548
    [No Abstract]   [Full Text] [Related]  

  • 38. Prescription medicines: the costs, the benefits, and the promise.
    Ingram RA
    N C Med J; 2003; 64(6):275-7. PubMed ID: 14983615
    [No Abstract]   [Full Text] [Related]  

  • 39. Report of the 2009 APhA House of Delegates: actions of the legislative body of the American Pharmacists Association.
    J Am Pharm Assoc (2003); 2009; 49(4):492-4. PubMed ID: 19589759
    [No Abstract]   [Full Text] [Related]  

  • 40. Public policy considerations in the pricing of prescription drugs in the United States.
    Rucker TD
    Int J Health Serv; 1974; 4(1):171-9. PubMed ID: 4829895
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.